528 related articles for article (PubMed ID: 10490909)
21. Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits.
Ootsuka Y; Blessing WW
Brain Res; 2006 Feb; 1073-1074():252-61. PubMed ID: 16455061
[TBL] [Abstract][Full Text] [Related]
22. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
23. Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity.
Fornal CA; Martín FJ; Mendlin A; Metzler CW; Bjorvatn B; Jacobs BL
Eur J Pharmacol; 1999 Jul; 377(2-3):187-91. PubMed ID: 10456429
[TBL] [Abstract][Full Text] [Related]
24. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
26. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
[TBL] [Abstract][Full Text] [Related]
27. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
28. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
Chidlow G; Nash MS; De Santis LM; Osborne NN
Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
[TBL] [Abstract][Full Text] [Related]
29. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
Sakai K; Crochet S
Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008
[TBL] [Abstract][Full Text] [Related]
30. Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.
Sahibzada N; Ferreira M; Wasserman AM; Taveira-DaSilva AM; Gillis RA
J Pharmacol Exp Ther; 2000 Feb; 292(2):704-13. PubMed ID: 10640309
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the serotonin1A receptor antagonist activity of WAY-100135 and spiperone.
Escandon NA; Zimmermann DC; McCall RB
J Pharmacol Exp Ther; 1994 Jan; 268(1):441-7. PubMed ID: 8301586
[TBL] [Abstract][Full Text] [Related]
32. Functional topography of brain serotonergic pathways in the rat.
Hillegaart V
Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
[TBL] [Abstract][Full Text] [Related]
33. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
Lejeune F; Millan MJ
Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
[TBL] [Abstract][Full Text] [Related]
34. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
[TBL] [Abstract][Full Text] [Related]
35. Single-unit responses of serotonergic medullary raphe neurons to cardiovascular challenges in freely moving cats.
Martin-Cora FJ; Fornal CA; Jacobs BL
Eur J Neurosci; 2005 Dec; 22(12):3195-204. PubMed ID: 16367786
[TBL] [Abstract][Full Text] [Related]
36. Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain.
Prisco S; Cagnotto A; Talone D; De Blasi A; Mennini T; Esposito E
J Pharmacol Exp Ther; 1993 May; 265(2):739-44. PubMed ID: 8496820
[TBL] [Abstract][Full Text] [Related]
37. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
Carli M; Balducci C; Samanin R
Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus.
Duncan MJ; Davis VA
Brain Res; 2005 Oct; 1058(1-2):10-6. PubMed ID: 16150426
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
Kreiss DS; Lucki I
J Pharmacol Exp Ther; 1994 Jun; 269(3):1268-79. PubMed ID: 8014870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
